Printer Friendly

Articles from M2 Pharma (April 19, 2018)

1-24 out of 24 article(s)
Title Author Type Words
Advaxis Presents Preclinical Data on Immunotherapy with Potential to Target Hotspot Cancer Mutations across Multiple Cancer Types at The AACR Annual Meeting. 269
ALK Abello announces securing of pricing by its Japanese partner for new Japanese cedar SLIT-tablet. 291
ANI Pharmaceuticals awarded US FDA's approval for generic Morphine Sulfate Oral Solution. 163
ArQule Licenses Basilea to Develop and Commercialise for Derazantinib. 430
Cantel Medical announces US FDA's 510(k) clearance to market ADVANTAGE PLUS Pass-Thru automated endoscope reprocessor. 243
Catabasis Pharmaceuticals to restructure resources. 170
Deciphera Pharmaceuticals Presents Phase 1 Clinical Trial Data on DCC-2618 at 2018 AACR Annual Meeting. 310
Direct-to-Consumer Telehealth Platform for Healthcare Providers Now Available from AMD Global Telemedicine. 216
Genentech Garners Breakthrough Therapy Designation for Hemlibra (emicizumab-kxwh) in Hemophilia A without Factor VIII Inhibitors. 260
Lundin Petroleum provides Q1 2018 financial update. 131
Magellan Rx Management Provides Results from Hemophilia Management Program. 405
Mobidiag Launches Diagnostic Test for on-Demand Detection of Bacterial Pathogens. 209
Motif Bio to present new iclaprim data at ECCMID 2018. 216
NeuroVive secures US FDA's orphan drug designation for KL1333 for treating mitochondrial diseases. 311
Novartis appoints Dr John Tsai as CMO and head of global drug development. 285
Novartis to invest USD100m to advance research and development of new antimalarials. 144
Obsidian Therapeutics Data Show Ability of Destabilising Domain Technology Platform to Regulate Expression of Secreted and Membrane-Bound Proteins in Cell Therapies. 262
Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. 360
Smith & Nephew names Namal Nawana new chief executive officer. 135
Syros Preclinical Data Demonstrate Potent Anti-Tumor Activity of SY-1365 in Multiple Models of Heavily Pretreated Ovarian Cancer. 415
Targovax names new director. 138
Taris Presents Preclinical Data on Effects of Low-Dose Bladder Delivery of Gemcitabine at AACR Annual Meeting. 277
Tetherex Pharmaceuticals concludes USD50m Series B financing. 167
US FDA grants breakthrough therapy designation to Roche's Hemlibra. 241

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters